Precision Neuroscience, a brain-computer interface (BCI) technology company, announced that it has closed an oversubscribed $250 million Series D financing round, co-led by Pershing Square Inc., the Ackman Oxman Institute, and an undisclosed leading life sciences investment fund. Additional participants include the Duquesne Family Office, B Capital, ARK Invest, Invus, Mubadala Capital, Mirae Asset Capital, Korea Investment Partners, Hitachi Ventures, JSL Health Capital, and others.